Skip to content
Get alerts
GovInfoNow
Use caution Drug recall · FDA · Published April 19, 2024

Nomax GloStrips Ophthalmic Strips Recall: Impurities Risk Eye Injury

Nomax recalls GloStrips eye drops due to impurities in the fluorescein sodium. These strips may cause eye injury if used. Affected lots expire by June 2024. Contact for return instructions.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0462-2024DrugNomax ›
Take action

Contact the company

Recalling firmNomax Inc9735 Green Park Industrial Dr · Saint Louis, MO 63123-7241
✎ GovInfoNow plain-language explainer

Nomax is recalling GloStrips eye drops because they contain impurities that could harm your eyes. This recall affects specific lots that expire by June 2024. The product is prescription-only and must be returned if you have it. Read more at govinfonow.com/recall/32724-nomax-glostrips-ophthalmic-strips-recall-impurities-risk-eye-injury.

Source Summary by GovInfoNow · govinfonow.com/recall/32724-nomax-glostrips-ophthalmic-strips-recall-impurities-risk-eye-injury · Updated August 17, 2026 · FDA enforcement record: FDA #D-0462-2024

Cite this page

“Nomax GloStrips Ophthalmic Strips Recall: Impurities Risk Eye Injury.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32724-nomax-glostrips-ophthalmic-strips-recall-impurities-risk-eye-injury. Based on FDA recall #D-0462-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0462-2024%22&limit=1).

The FDA announced on April 19, 2024, that Nomax Inc is recalling GloStrips, Fluorescein Sodium Ophthalmic Strips USP (0.6 mg) due to failed impurity specifications. The agency issued recall number D-0462-2024 for the voluntary Class II action.

How to tell if you have it

  • Brand: Nomax
  • Product: GloStrips, Fluorescein Sodium Ophthalmic Strips USP (0.6 mg Fluorescein), Rx Only
  • NDC 51801-003-40: 100 strips per carton
  • NDC 51801-003-50: 300 strips per carton
  • Lot #s: a) 14904, Exp. 06/30/2024; Lot 14938, Exp. 07/31/2024; b) Lot 14931, Exp. 06/30/2024
  • Distribution: Nationwide in the USA

The hazard

According to the FDA, the Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph regarding Unspecified Impurities. The recall involves 15,056 cartons distributed nationwide.

Context

GovInfoNow's records show Nomax Inc has two other recalls on record since March 24, 2015. Other recent recalls of similar products include Scope Health Optase Dry Eye Drops Recall (April 20, 2026), Imprimis Dexamethasone Moxifloxacin Eye Drops Recall (December 18, 2025), and Rohto Cooling Eye Drops Max Strength Recall (July 14, 2026).

How to tell if you have this one

Check the carton for 'GloStrips, Fluorescein Sodium Ophthalmic Strips USP (0.6 mg Fluorescein), Rx Only'. Look for specific lot numbers: 14904 (expiring June 30, 2024), 14938 (expiring July 31, 2024), or 14931 (expiring June 30, 2024).

  • Brand
    Nomax
  • Category
    Drug
FDA recall event · 4 products

All 4 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Nationwide in the USA
Recall numberProduct, codes & lotsQuantityNDC
D-0462-2024GloStrips, Fluorescein Sodium Ophthalmic Strips USP (0.6 mg Fluorescein), Rx Only, a) 100 strips per carton, NDC 51801-003-40; b) 300 strips per carton, NDC 51801-003-50, Nomax, Inc., St. Louis, MO 63123.; Lot #s: a) 14904, Exp. 06/30/2024; Lot 14938, Exp. 07/31/2024; b) Lot 14931, Exp. 06/30/202415,056 cartons51801-003-50, 51801-003-40
D-0463-2024GloStrips, Fluorescein Sodium Ophthalmic Strips USP (1.0 mg Fluorescein), Rx Only, 100 Sterile Strips per carton, Nomax, Inc., St. Louis, MO 63123, NDC 51801-009-40.; Lot #: 14708, Exp. 04/30/2024.6,960 cartons51801-009-50, 51801-009-40
D-0464-2024FUL-GLO, Fluorescein Sodium Sterile Ophthalmic Strips USP (0.6 mg Fluorescein), 300 sterile strips per carton, Manufactured for: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-403-03.; Lot 14842, Exp. 6/30/20244648 cartons—
D-0465-2024FUL-GLO, Fluorescein Sodium Ophthalmic Strips USP 1 mg, 100 sterile strips per carton, Manufactured for: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-404-01.; Lot #: 14776, Exp. 05/31/2024.15,444 cartons—
Based on the official FDA remedy

What to do — step by step

  1. Check Product Lot Number

    Look for lot numbers 14904, 14938, or 14931 on the carton label.

  2. Return Recalled Product

    Contact Nomax Inc for instructions to return the product if you have the recalled lots.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 12 days after the firm started it.

1. Firm started the recall: Apr 19, 202412. FDA classified it Class II: Apr 23, 202423. Published in FDA’s Enforcement Report: May 1, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

American Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, IncPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INCApothecary Pharma Recalls Tirzepatide Injections Due to Sterility Risk
Apothecary Pharma LLC

Latest drug recalls

Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026K.C. Pharmaceuticals, Inc. recalls Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO
Leader / TopCare / Crocodile Tears · September 11, 2026Amneal Pharmaceuticals, LLC recalls Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater,
Amneal Pharmaceuticals · September 8, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0462-2024 (April 19, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0462-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA